Vasar, Eero

Association study of 90 candidate gene polymorphisms in panic disorder

Maron, E., Nikopensius, T., K??ks, S., Altm??e, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Koido, K., Kurg, A., et al. (2005) · Psychiatric Genetics

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 89

Neural cell adhesion molecule Negr1 deficiency in mouse results in structural brain endophenotypes and behavioral deviations related to psychiatric disorders

Singh, K., Jayaram, M., Kaare, M., Leidmaa, E., Jagomäe, T., Heinla, I., Hickey, M. A., Kaasik, A., Schäfer, M. K., Innos, J., et al. (2019) · Scientific Reports

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 65

Melanocytes in the Skin – Comparative Whole Transcriptome Analysis of Main Skin Cell Types

Reemann, P., Reimann, E., Ilmjärv, S., Porosaar, O., Silm, H., Jaks, V., Vasar, E., Kingo, K., & Kõks, S. (2014) · PLoS ONE

melanin and skin pigmentationMelanoma and MAPK Pathways

Cited by 64

Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam

Bentué-Ferrer, D., Reymann, J. M., Tribut, O., Allain, H., Vasar, E., & Bourin, M. (2001) · European Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 30

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Heinla, K., Vasar, E., Reppo, I., Sedman, T., & Volke, V. (2023) · Diabetes Therapy

Growth Hormone and Insulin-like Growth FactorsDiabetes Treatment and Management

Cited by 30